Use of Orthobiologics to Improve Pain and Function for Varied Pathoanatomic Diagnoses of the Knee

Principal Investigator:

Dr. Joel Baumgartner

MD, University of North Dakota School of Medicine

Dr. Joel Baumgartner is a board-certified physician with a specialized fellowship in non-surgical orthopedics and sports medicine.  He utilizes the latest in diagnostic and treatment technology to better treat musculoskeletal injury and pain, and has authored a book on Prolotherapy and PRP technique.

Study Abstract:

This Circle, designed for practitioners at Rejuv Medical and other orthopedists around the world, captures pain, function, and stiffness symptoms pre- and post-administration of PRP injections over a 12-month period for various knee pathologies.  Specifically, this Circle evaluates the safety and efficacy of a one-time treatment of orthobiologics products such as APEX Protein Concentration Kit, XCELL BMC, and XCELL PRP.

Study Type:

Interventional, Quality Improvement

Circle Benefits:
  • Longitudinal, real-world safety and efficacy assessment of PRP.
  • Collaboration with nationally recognized musculoskeletal physicians.
  • Participate and benefit from clinically significant registry datasets supporting standards of care for a variety of musculoskeletal indications.
Real-World Data Surveys:
  • Visual Analogue Scale (VAS)
  • Western Ontario and McMaster Universities Arthritis Index (WOMAC)
Circle Type:
locked lock icon for private circles

Private Circle

Interested in learning more about this Circle?

Related Posts

No items found.
Additional Resources:

Use of Orthobiologics to Improve Pain and Function for Varied Pathoanatomic Diagnoses of the Knee

Circle Objective Abstract:

This Circle, designed for practitioners at Rejuv Medical and other orthopedists around the world, captures pain, function, and stiffness symptoms pre- and post-administration of PRP injections over a 12-month period for various knee pathologies.  Specifically, this Circle evaluates the safety and efficacy of a one-time treatment of orthobiologics products such as APEX Protein Concentration Kit, XCELL BMC, and XCELL PRP.

Real-World Data Surveys:

VAS, WOMAC

Intervention:

Circle Benefits:
  • Longitudinal, real-world safety and efficacy assessment of PRP.
  • Collaboration with nationally recognized musculoskeletal physicians.
  • Participate and benefit from clinically significant registry datasets supporting standards of care for a variety of musculoskeletal indications.

Streamlined patient enrollment, real-world data capturing, heightened recognition, prominence and collaboration

Circle Type:
locked lock icon for private circles

Private Circle

Supporting Materials
Interested in learning more about this Circle?

CIRCLE LIBRARY

CIRCLE NAME

Total Knee Arthroplasty Outcome-Based Performance Measure

SURVEYS

OUTCOMES SURVEYS

VAS
KOOS Jr.
VR-12 (compliant with CMS/IQR Requirements)

CLINICAL SURVEYS

As specified by Provider

THIS CIRCLE IS FOR:

Provider Receiving CMS Reimbursement For TKAs

CMS will soon penalize providers performing total knee replacements which do not collect specified outcomes data from at least 50% of qualifying patients.

Other Providers Performing TKAs

Private insurance companies and other payers within and outside the U.S. will follow the CMS lead in requiring high patient compliance in reporting long-term TKA outcomes.

WHY CIRCLES

Patented technology
HIPAA, GDPR, GCP and Part 11 compliant
Multilingual
Scalable
Easily export to, integrate with, existing systems
Robust reporting functions
Illustrative Materials
Minimal administrative and clinical burden
Accommodates surgical variations
All data accessible 24/7 from any device
Allows extensive customization
Inherent collaboration among peers
Improves clinical decision-making
Adjustable outcomes alerts
Regular reports on key metrics
Automatic patient consent capture
Illustrative Materials
Sustained onboarding and follow-up processes
Communication of condition and protocol education materials *
Regular progress reports *
Cohort comparisons *
Newsletters, other patient communications *
*  Provider defined
Illustrative Materials
Clear ownership of validated anonymized datasets
Copyrightable
Right to publish
Right to monetize
Illustrative Materials
Not a point solution, but a strategic initiative
Easily extensible and scalable
Accommodates Health Equity initiatives
Accommodates CMS Hospital Value Program and other Value-Based Care initiatives
Clinical Grade
Patented technology
HIPAA, GDPR, GCP and Part 11 compliant
Multilingual
Scalable
Robust reporting functions
Easily export to, integrate with, existing systems
Interested in this Circle?

If you have any questions, please contact us.

ADDITIONAL RESOURCES